IL6 and ovarian carcinoma: Third, SHMT1 promotes ovarian cancer tumor growth and progression, in part, by facilitating expression of pro-oncogenic inflammatory cytokines IL-6 and IL-8, and, at least in part, by regulating cellular levels of Neu5Ac.